Joe Leigh Simpson, MD

Ob/gyns have a responsibility and can no longer be passive in this genomic era.

Patients are going to have direct-to-consumer genetic tests done, regardless of our position on the subject. At the very least, we can offer them sound advice on the matter.

Among the clinical issues to consider: Should PGD aneuploidy testing be offered to women of advanced maternal age?

We need to remember that screening is screening; it's great, but not perfect.

Conference Highlights

The latest official guidelines on cystic fibrosis screening have some clinicians bewildered--and others looking for an easy way to put them to good use. A top expert in the field provides practical advice on how to individualize the recommendations.